Gerald McLaughlin
Director Ejecutivo en NEOS THERAPEUTICS, INC. .
Cargos activos de Gerald McLaughlin
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ALLARITY THERAPEUTICS, INC. | Independent Dir/Board Member | 01/10/2022 | - |
Presidente | 19/01/2023 | - | |
Director/Miembro de la Junta | 01/10/2022 | 19/01/2023 | |
NEOS THERAPEUTICS, INC. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Director/Miembro de la Junta | 01/07/2021 | - |
Director Ejecutivo | 01/07/2021 | - | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Independent Dir/Board Member | 01/10/2022 | - |
Presidente | - | - | |
Director/Miembro de la Junta | 01/10/2022 | - |
Historial de carrera de Gerald McLaughlin
Antiguos cargos conocidos de Gerald McLaughlin.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AYTU BIOPHARMA, INC. | Director/Miembro de la Junta | 19/03/2021 | 17/05/2021 |
NEOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 27/06/2018 | 19/03/2021 |
Director Ejecutivo | 27/06/2018 | 19/03/2021 | |
Presidente | 27/06/2018 | 19/03/2021 | |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Director/Miembro de la Junta | 01/06/2014 | 01/06/2018 |
Director Ejecutivo | 01/06/2014 | 01/06/2018 | |
Presidente | 01/06/2014 | 01/06/2018 | |
SKYE BIOSCIENCE, INC. | Director/Miembro de la Junta | 01/10/2014 | 18/01/2018 |
Independent Dir/Board Member | 01/10/2014 | 18/01/2018 | |
NUPATHE INC | Director de Operaciones | 01/09/2007 | 21/06/2011 |
Public Communications Contact | 21/06/2011 | 21/06/2012 | |
Corporate Officer/Principal | 21/06/2011 | 01/03/2014 | |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Gerald McLaughlin.
Dickinson College | Undergraduate Degree |
Villanova School of Business | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 12 |
Dinamarca | 2 |
Operativa
Director/Board Member | 8 |
Chief Executive Officer | 4 |
Independent Dir/Board Member | 3 |
Sectorial
Health Technology | 10 |
Consumer Services | 3 |
Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
SKYE BIOSCIENCE, INC. | Health Technology |
AYTU BIOPHARMA, INC. | Health Technology |
ALLARITY THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
NuPathe, Inc.
NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
Neos Therapeutics, Inc.
Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Gerald McLaughlin
- Experiencia